Information supplied on Ose-immuno.com is for information purposes only and may expressly or implicitly contain certain forward-looking statements concerning OSE Immunotherapeutics and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of OSE Immunotherapeutics to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. OSE Immunotherapeutics does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise. For a discussion of risks and uncertainties which could cause actual results, financial condition, performance or achievements of OSE Immunotherapeutics to differ from those contained in the forward-looking statements, please refer to the OSE Immunotherapeutics Reference Document filed with the AMF on 26 April 2018, including the annual financial report for the fiscal year 2017, available on the OSE Immunotherapeutics website.
Cookies are used to record how many visitors view the content and to assess how user-friendly the website is. This information is not cross-referenced with any other data processing. Anonymous statistics generated in this way are intended for Ose Immunotherapeutics and its sub-contractors. Use of the IP address for geolocation is limited to information about the town. Any information collected using cookies is kept for a maximum of twelve months.